Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feher

Showing results (561-570 of 1,028) with videos related to

Pageof 103
Sort By:
Gynecologic Oncology|March 16, 2006
Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literatureFernando Cotait Maluf, Jesus Paula Carvalho, Filomena Marino Carvalho, et al.
Journal of Neurochemistry|April 12, 2002
Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidationAnthony S Wierzbicki, Matthew D Lloyd, Christopher J Schofield, et al.
Current Medicinal Chemistry|December 17, 2008
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measuresF De Lorenzo, S Collot-Teixeira, M Boffito, et al.
Journal of Human Hypertension|June 1, 1996
Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertensionT C Hardman, A S Wierzbicki, P Croft, et al.
Journal of Immunological Methods|July 31, 2012
A flow cytometry based competitive fluorescent microsphere immunoassay (CFIA) system for detecting up to six mycotoxinsArpad Czeh, Frank Mandy, Szilvia Feher-Toth, et al.
JMIR Research Protocols|July 19, 2022
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)Michael Feher, William Hinton, Anna Forbes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Structure of the reaction center from Rhodobacter sphaeroides R-26 and 2.4.1: protein-cofactor (bacteriochlorophyll, bacteriopheophytin, and carotenoid) interactionsT O Yeates, H Komiya, A Chirino, et al.
Rheumatology (Oxford, England)|February 22, 2003
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and goutM D Feher, A L Hepburn, M B Hogarth, et al.
Current Medicinal Chemistry|December 16, 2006
Statin therapy-evidence beyond lipid lowering contributing to plaque stabilityFerruccio de Lorenzo, Michael Feher, Juliette Martin, et al.
Journal of Human Hypertension|August 1, 1995
Association of angiotensin converting enzyme DD genotype with hypertension in diabetesA S Wierzbicki, L Nimmo, M D Feher, et al.
Pageof 103

Showing results (561-570 of 1,028) with videos related to

Sort By:
Pageof 103
Gynecologic Oncology|March 16, 2006
Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literatureFernando Cotait Maluf, Jesus Paula Carvalho, Filomena Marino Carvalho, et al.
Journal of Neurochemistry|April 12, 2002
Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidationAnthony S Wierzbicki, Matthew D Lloyd, Christopher J Schofield, et al.
Current Medicinal Chemistry|December 17, 2008
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measuresF De Lorenzo, S Collot-Teixeira, M Boffito, et al.
Journal of Human Hypertension|June 1, 1996
Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertensionT C Hardman, A S Wierzbicki, P Croft, et al.
Journal of Immunological Methods|July 31, 2012
A flow cytometry based competitive fluorescent microsphere immunoassay (CFIA) system for detecting up to six mycotoxinsArpad Czeh, Frank Mandy, Szilvia Feher-Toth, et al.
JMIR Research Protocols|July 19, 2022
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)Michael Feher, William Hinton, Anna Forbes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Structure of the reaction center from Rhodobacter sphaeroides R-26 and 2.4.1: protein-cofactor (bacteriochlorophyll, bacteriopheophytin, and carotenoid) interactionsT O Yeates, H Komiya, A Chirino, et al.
Rheumatology (Oxford, England)|February 22, 2003
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and goutM D Feher, A L Hepburn, M B Hogarth, et al.
Current Medicinal Chemistry|December 16, 2006
Statin therapy-evidence beyond lipid lowering contributing to plaque stabilityFerruccio de Lorenzo, Michael Feher, Juliette Martin, et al.
Journal of Human Hypertension|August 1, 1995
Association of angiotensin converting enzyme DD genotype with hypertension in diabetesA S Wierzbicki, L Nimmo, M D Feher, et al.
Pageof 103